当前位置：首页 > 文献互助 > 互助详情

Recent Advances and Challenges of Electrocatalytic N2Reduction to Ammonia复制

用户nFgq880AqUj8 12分钟前 9 10 待确认 帖子自动结束时间: 2026-05-31 12:18:41

1. 请及时下载文件确认是否正确, 系统将在 2026-06-02 12:19:50 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1021/acs.chemrev.9b00659复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.chemrev.9b00659复制

其他信息:

出版社: American Chemical Society (ACS)
作者: Geletu Qing; Reza Ghazfar; Shane T. Jackowski; Faezeh Habibzadeh; Mona Maleka Ashtiani; Chuan-Pin Chen; Milton R. Smith; Thomas W. Hamann

上一篇：附件附件求附件！！In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia

互助时间线

2026-05-26 12:19:50 [上传文件]

小小探险上传了文件(pdf 23.93 MB), 求助状态变成 待确认

2026-05-26 12:18:41 [发起求助]

最新发布的求助

Recent Advances and Challenges of Electrocatalytic N2Reduction to Ammonia 12分钟前
附件附件求附件！！In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia 20分钟前
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia 23分钟前
Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors 26分钟前
Selective and Potent Molecular Glue Degraders for NIMA-Related Kinase 7 28分钟前
Silylated Melamine and Cyanuric Acid as Precursors for Imprinted and Hybrid Silica Materials with Molecular Recognition Properties 38分钟前
Hydrophilic nano-SiO2/PVA-based coating with durable antifogging properties 1小时前
Trial of the Oral PCSK9 Inhibitor Enlicitide. Reply 1小时前
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference 1小时前
Oral epinastine vs loratadine in seasonal allergic rhinitis: A randomized, double‑blind, placebo‑controlled trial 1小时前
Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS 1小时前
Phase 3 study results for oral PCSK9 inhibition with enlicitide 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com